Gilead Sciences

Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff of more than 7,000 people is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone has a chance to enhance their skills through ongoing development. Our scientific focus has resulted in 19 marketed products that are benefitting hundreds of thousands of people, a pipeline of late-stage drug candidates and unmatched patient access programs to ensure medications are available to those who could otherwise not afford them. Today, Gilead's research and development effort is the largest it has ever been and includes approximately 200 clinical studies evaluating compounds with the potential to become the next generation of innovative therapies for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. The commercial success of Gilead's portfolio of 19 products has provided the company with the resources to support the development of new therapeutic advancements. Working at Gilead provides you with plenty of opportunities for career advancement in a growing and fast-paced environment while working with highly-respected teams. We would like to invite you to be a part of the following Gilead organizations that have helped millions of people around the world live healthier and more fulfilling lives.
Foster City, US
8,000 (est)+15%
Gilead Sciences was founded in 1987 and is headquartered in Foster City, US

Gilead Sciences Locations

Foster City, US
Solna, SE
Stockholm, SE
Hod Hasharon, IL
Tel Aviv-Yafo, IL
Amsterdam, NL
Edmonton, CA
Shanghai, CN
San Francisco, US
Seoul, KR
Seattle, US
Branford, US
San Dimas, US
Oceanside, US
Fremont, US
Johannesburg, ZA
Mississauga, CA
Lisbon, PT
Bangkok, TH

Gilead Sciences Metrics

Gilead Sciences Summary

Market capitalization

$95 B

Closing share price

Gilead Sciences's current market capitalization is $95 B.

Gilead Sciences Financials

Gilead Sciences's revenue is $32.6 B in FY, 2015 which is 31.13% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$11.2 B$24.9 B$32.6 B

Gross profit

$8.34 B$21.1 B$28.6 B

Operating income

$4.52 B$15.3 B$22.2 B

Operating expense total

$3.82 B$5.84 B$6.44 B

Net Income

$3.06 B$12.1 B$18.1 B

Operating cash flow

$309 M$7.91 B$2.82 B

    Gilead Sciences Market Value History

    Gilead Sciences Online Presence

    Gilead Sciences News

    Gilead Sciences Company Life

    You may also be interested in